Moreover, CSPG4 expression has been corroborated not only on differentiated cancer cells but also on cancer stem/initiating cells (CIC), considered responsible for recurrences and metastasis, therefore making the CSPG4 an even more interesting target for immunotherapy. This evidence concerns the gene CSPG4 and cancer.